Eosinophilic pneumonia associated with pirfenidone therapy

Eur Respir J. 2016 Oct;48(4):1240-1242. doi: 10.1183/13993003.00809-2016. Epub 2016 Jul 7.

Authors

Diana C Gomez¹, Borna Mehrad²

Affiliations

¹ Interstitial Lung Disease Program, Division of Pulmonary and Critical Care Medicine, University of Virginia, Charlottesville, VA, USA.
² Interstitial Lung Disease Program, Division of Pulmonary and Critical Care Medicine, University of Virginia, Charlottesville, VA, USA The Carter Center for Immunology, University of Virginia, Charlottesville, VA, USA mehrad@virginia.edu.

No abstract available

Publication types

Case Reports
Letter
Research Support, N.I.H., Extramural

MeSH terms

Aged
Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
Computed Tomography Angiography
Humans
Idiopathic Pulmonary Fibrosis / diagnostic imaging
Idiopathic Pulmonary Fibrosis / drug therapy*
Lung / diagnostic imaging*
Male
Pulmonary Eosinophilia / chemically induced*
Pulmonary Eosinophilia / diagnostic imaging
Pyridones / adverse effects*
Tomography, X-Ray Computed

Substances

Anti-Inflammatory Agents, Non-Steroidal
Pyridones
pirfenidone

Grants and funding